Target intelligence / Profile preview

Oxycodone Prodrug Activation (Trypsin-Mediated)

Molecular classification
Enzyme-mediated drug release/activation
01

Overview

Oxycodone prodrug activation (trypsin-mediated) is a drug delivery strategy employing trypsin, a serine protease primarily in the small intestine, to activate inactive oxycodone prodrugs. This approach aims to improve the safety profile and reduce misuse risk compared to immediate-release opioids by releasing oxycodone primarily in the small intestine after oral administration. The prodrug undergoes proteolytic cleavage by trypsin, followed by intramolecular cyclization, to release active oxycodone.

02

Mechanism of action

Proteolytic cleavage by trypsin followed by intramolecular cyclization, resulting in oxycodone release.

03

Biological functions

Drug activation
04

Disease associations

Pain management
05

Safety considerations

Potential for inter-patient variability in trypsin activity.Risk of incomplete prodrug conversion.Influence of intestinal environment on activation efficiency.
06

Interacting drugs

Oxycodone prodrugs (e.g., PF614)

1 more in the full profile.

Beyond the preview

Go deeper on Oxycodone Prodrug Activation (Trypsin-Mediated).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxycodone Prodrug Activation (Trypsin-Mediated).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call